JamesFrancisAmatrudaMDPhD
Pediatric Hematology & Oncology • Los Angeles, CAPediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology
Professor, Pediatrics and Medicine, Keck School of Medicine, University of Southern California. Director, Basic and Translational Research, Cancer and Blood Disease Institute, Children's Hospital Los Angeles.
Dr. Amatruda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Children's Hospital Los Angeles
4650 Sunset Boulevard
Los Angeles, CA 90027- Is this information wrong?
Summary
- Dr. James Amatruda is an oncologist in Los Angeles, CA and is affiliated with Children's Hospital Los Angeles. He received his medical degree from Washington University School of Medicine in St. Louis and has been in practice 24 years. He specializes in pediatric solid tumors including germ cell tumors, sarcomas and kidney tumors..
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1997 - 2000- Brigham and Women's HospitalResidency, Internal Medicine, 1993 - 1996
Washington University in St. Louis School of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 2019 - 2025
TX State Medical License 2005 - 2019
MA State Medical License 1995 - 2006- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsIntegrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence.Lin Xu, Joshua L Pierce, Angelica Sanchez, Kenneth S Chen, Abhay A Shukla, Nicholas J Fustino, Sarai H Stuart, Aditya Bagrodia, Xue Xiao, Lei Guo, Mark D Krailo, Furqa...> ;Nature Communications. 2023 May 6
- 8 citationsCombined low-pass whole genome and targeted sequencing in liquid biopsies for pediatric solid tumors.Eirini Christodoulou, Venkata Yellapantula, Katrina O'Halloran, Liya Xu, Jesse L Berry, Jennifer A Cotter, Anya Zdanowicz, Leo Mascarenhas, James F Amatruda, Dejeriann...> ;NPJ Precision Oncology. 2023 Feb 20
- VGLL2-NCOA2 leverages developmental programs for pediatric sarcomagenesis.Sarah Watson, Collette A LaVigne, Lin Xu, Didier Surdez, Joanna Cyrta, Delia Calderon, Matthew V Cannon, Matthew R Kent, Katherine M Silvius, Jack P Kucinski, Emma N H...> ;Cell Reports. 2023 Jan 31
- Join now to see all
Press Mentions
Children’s Hospital Los Angeles Develops Liquid Biopsy Test for Pediatric Solid TumorsMarch 2nd, 2023
Scientists Identify New Mechanisms Underlying Pediatric Kidney CancerAugust 1st, 2018
Pulling Together: Boy Bravely Confronts Cancer Diagnosis — TwiceJuly 13th, 2018- Join now to see all
Grant Support
- Generation And Rapid Mapping Of Low-Penetrance Disease Alleles In ZebrafishNational Cancer Institute2008–2011
- Chemical Disruption Of The HH And WNT Pathways In Vertebrate DevelopmentEunice Kennedy Shriver National Institute Of Child Health &Human Development2009–2010
- Tumor Suppressors Hematopoiesis And LeukemiaNational Heart, Lung, And Blood Institute1999–2003
Hospital Affiliations
Children's Hospital Los AngelesLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
